Enrollment change • Combination therapy • IO biomarker • Metastases
|
KRAS (KRAS proto-oncogene GTPase) • IL6 (Interleukin 6) • IL2 (Interleukin 2) • IL10 (Interleukin 10)
|
PD-L1 expression • KRAS mutation • MSI-H/dMMR • KRAS G12C • KRAS G12D • KRAS G12V • KRAS G12
|
albumin-bound paclitaxel • cyclophosphamide • KRAS-EphA-2-CAR-DC